March/April, 2011, Vol. 11, Num. 2

Epilepsy Currents, March/April, 2011, Vol. 11, Num. 2
Table of Contents

Clinical Science - Current Review

Explaining the Unexplained; Expecting the Unexpected:Where Are We With Sudden Unexpected Death in Epilepsy? 
Elizabeth J. Donner, MD, FRCPC

Clinical Science - Current Literature

Brand Spanking? The Presumptive Risks of Generic Antiepileptic Drugs 
Scott Mintzer, MD

Interpreting Seizure Counts After Temporal Lobectomy:Not Just One-Two-Three 
Warren T. Blume, M.D.

Is Depression a Risk Factor of Worse Response to Therapy in Epilepsy? 
Andres M. Kanner, MD

Basic Science - Current Review

Revisiting AMPA Receptors as an Antiepileptic Drug Target 
Michael A. Rogawski

Basic Science - Current Literature

A Persistent Little Current With a Big Impact on Epileptic Firing 
Carl E. Stafstrom, MD, PhD

Rapamycin for Treatment of Epilepsy: Antiseizure, Antiepileptogenic, Both, or Neither? 
Michael Wong, MD, PhD